The 2024 annual reports of major Chinese IVD companies released.

Chinese President Xi Jinping said here Thursday that building a China-Cambodia community with a shared future is a choice of history and the people.

An Epic Approach Toward Liquid Biopsy 液体活检 史诗般的方法 The liquid biopsy space continues to attract investors and bring in financings that are typically above the average amount medtech firms are able to raise. Epic Sciences

Medical device designers have a new research tool in their arsenal that facilitates faster immersion for the development team and provides a communication platform to bring patients and healthcare professionals into the development process.

Biodesix Makes the Case for VeriStrat Through New Study Biodesix通过新的研究证明了VeriStrat的可行性 The Biodesix VeriStrat test received an extra dose of validation last week through a 1,048-patient study published in the Oncol

Ortho Clinical Diagnostics, a global leader in diagnostic platforms and technologies, recently announced that its new digital chemistry system known as the VITROS XT 7600 has received the CE mark ahead of its launch overseas. The new technol

Bacterial or viral infection, that is the question. Haifa-Israel based MeMed Diagnostics is developing a point-of-care platform and immune-based test that will one day be able to provide answers. Such a test could help with the overuse and u

Nebula Genomics has raised $4.3 million in seed financing from venture capital firms and has also partnered with Veritas Genetics, the company said recently. Nebula, which was founded last year by Harvard University researchers including Ge

Nebula Genomics has raised $4.3 million in seed financing from venture capital firms and has also partnered with Veritas Genetics, the company said recently. Nebula, which was founded last year by Harvard University researchers including Ge

Illumina said recently that it has received regulatory clearance for its MiSeqDx system from the China National Drug Administration, enabling it to sell the system in China for diagnostic testing. The clearance of the MiSeqDx in China is a

In 2012, genetic testing company 23andMe announced the opening of its Application Programming Interface (API), which wasintended to empower developers to build a wide range of new applications and tools for the 23andMe community.Six years la

Roche said recently that the US Food and Drug Administration has approved its Cobas EGFR Mutation Test v2 as a companion diagnostic test with AstraZenecas cancer drug Iressa (gefitinib) for first-line treatment of patients with non-small ce